Clinical Trial Detail

NCT ID NCT02133196
Title T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Aldesleukin + Cyclophosphamide + Fludarabine

Age Groups: adult senior

No variant requirements are available.